Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-9,856,349 |
Catalysts and methods for polymer synthesis The present invention provides bimetallic complexes having increased activity in the copolymerization of carbon dioxide and epoxides. Also provided are methods... |
| US-9,856,348 |
Multifunctional degradable nanoparticles with control over size and
functionalities In one aspect, the invention relates to polymers, crosslinked polymers, functionalized polymers, nanoparticles, and functionalized nanoparticles and methods of... |
| US-9,856,347 |
Curable composition, cured product thereof, and wafer level lens Provided is a curable composition that is rapidly cured to form a cured product. The cured product resists yellowing, successfully maintains excellent... |
| US-9,856,346 |
Lignin-based biomass epoxy resin, method for manufacturing the same, and
compositions including the same A method of forming a lignin-based biomass epoxy resin is provided, which includes: (a) mixing a lignin, an acid anhydride compound, and a solvent to react for... |
| US-9,856,345 |
Low viscosity dimethoxy amino silane polyurethane with triethoxy silyl
groups for sealants and adhesives with... The present method relates to the production of low viscosity dimethoxy amino silane polyurethane with triethoxy silyl groups, as well as the production of... |
| US-9,856,344 |
Reduction of aldehydes in amine catalysts The present disclosure provides a method for reducing the aldehyde content in an amine catalyst by treating the amine catalyst with an organic acid. The organic... |
| US-9,856,343 |
Renewable bio-based (meth)acrylated monomers as vinyl ester cross-linkers Anhydrosugar-based monomers prepared from isosorbide, isomannide, and isoidide and resin systems containing these anhydrosugar-based monomers that are partially... |
| US-9,856,342 |
Copolymer and molded body A copolymer comprising a structural unit (I) derived from a phosphonate monomer (1) such as diethyl methacryloyloxymethyl phosphonate, diethyl ... |
| US-9,856,341 |
Polymer, and electrolyte and lithium secondary battery including the same A polymer including a first repeating unit represented by Formula 1, a second repeating unit represented by Formula 2, and a third repeating unit: ##STR00001##... |
| US-9,856,340 |
Photocurable fluorinated polymer composition To provide a photocurable fluorinated polymer composition which has a high curing rate, shows little shrinkage before and after photocuring and requires no post... |
| US-9,856,339 |
Polyethylenes with increased molecular weight distribution Methods for making olefin polymerization catalysts and methods for making polyethylene polymers using the catalysts are provided. The polyethylenes can have a... |
| US-9,856,338 |
Processes to prepare ethylene-based polymers using a distribution of
carbon monoxide The invention provides a high pressure, free-radical polymerization process for polymerizing an ethylene-based polymer, said process comprising polymerizing... |
| US-9,856,336 |
Tetracyanoanthraquinodimethane polymers and use thereof Novel tetracyanoanthraquinodimethane polymers and use thereof. The problem addressed was that of providing novel polymers which are preparable with a low level... |
| US-9,856,335 |
Production of highly reactive low molecular weight PIB oligomers In one preferred embodiment, the present invention provides a process for the liquid phase polymerization of isobutylene to manufacture highly reactive PIB... |
| US-9,856,334 |
Cyclopolymeric zwitterion-dianionic resin and synthesis and uses thereof Cross-linked cyclopolymeric resins from N,N-diallyl quaternary ammonium monomers and tetrallylpiperazinium cross-linking monomer or salts, solvates, tautomers... |
| US-9,856,333 |
Polymerizable compound, polymerizable composition, polymer, and optically
anisotropic material The present invention relates to: a polymerizable compound (I), wherein Y.sup.1 to Y.sup.6 are a chemical single bond, --O--C(.dbd.O)--, --C(.dbd.O)--O-- or the... |
| US-9,856,332 |
Methods for high-throughput in-situ manufacture of user desired 3D
polymeric scaffolds Biomedical devices and methods are disclosed for the development of 3D polymeric scaffolds for cell culture, high throughput screens for biomolecule... |
| US-9,856,331 |
Control over reverse addition fragmentation transfer polymerization
processes A procedure for improved temperature control in controlled radical polymerization processes is disclosed. The procedure is directed at controlling the... |
| US-9,856,330 |
Diene elastomer modified by coupling having silanol functions, synthesis
method for same, and rubber... The present invention relates to a modified diene elastomer predominantly comprising a species coupled via a group bearing a function comprising a silicon atom... |
| US-9,856,329 |
Flame retardant modified cellulosic nanomaterials (FR-CNs) prepared using
phosphorus-containing monomers In accordance with some embodiments of the present invention, a composite material is prepared by blending a flame retardant modified cellulosic nanomaterial... |
| US-9,856,328 |
Methods for modifying nitrocellulose having lyophobic properties Described herein are methods for chemical modification of nitrocellulose to generate lyophobic properties which are useful in propellant compositions. Such... |
| US-9,856,327 |
Heterodimeric antibodies to CD3 X CD123 The present invention is directed to novel heterodimeric antibodies. |
| US-9,856,326 |
Methods of administering inhibitory anti-factor XII/XIIA monoclonal
antibodies The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use. |
| US-9,856,325 |
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal
antibodies The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use. |
| US-9,856,324 |
Human monoclonal antibodies to ganglioside GD2 The present invention provides compositions for the production of an antibody or functional fragment thereof directed against disialoganglioside-GD2. The... |
| US-9,856,323 |
Anti-CD22 antibodies Anti-CD22 antibodies, including isolated nucleic acids that encode at least one such anti-CD22 antibody, vectors, host cells, transgenic animals or plants, and... |
| US-9,856,322 |
Chimeric receptors with 4-1BB stimulatory signaling domain The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the... |
| US-9,856,321 |
Anti-DR5 antibodies, polynucleotides and methods The present invention relates to an antibody which has a therapeutic effect on cancer, an autoimmune disease, or an inflammatory disease. That is, the present... |
| US-9,856,320 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling The disclosure provides a method for immunotherapy of a cancer patient, comprises administering to the patient an Ab that inhibits signaling from the PD-1/PD-L1... |
| US-9,856,319 |
Monovalent binding proteins Engineered monovalent binding proteins that bind to one or more ligands (such as an antigen) via one binding domain are provided, along with methods of making... |
| US-9,856,318 |
Reducing systemic regulatory T cell levels or activity for treatment of
disease and injury of the CNS A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a... |
| US-9,856,317 |
Human antibody molecules for IL-13 Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13... |
| US-9,856,316 |
Antibodies targeting M-CSF This disclosure generally relates to antibodies or antibody fragments which specifically bind to M-CSF. In particular antibodies and antibody fragments are... |
| US-9,856,315 |
Methylation and acetylation sites The disclosure features over 5000 methylation and acetylation sites identified in human cell line, human serum and mouse tissues, peptides (including AQUA... |
| US-9,856,314 |
Activatable antibodies having non-binding steric moieties and methods of
using the same The invention relates generally to activatable antibodies and methods of making and using these activatable antibodies in a variety of therapeutic, diagnostic... |
| US-9,856,313 |
Epitope of RSV fusion protein and antibody recognizing the same The present invention relates to an epitope peptide (or a variant thereof) which can be used in the prevention of respiratory syncytial virus (RSV) infection, a... |
| US-9,856,312 |
Binding molecule having influenza A virus-neutralizing activity produced
from human B cell The present invention relates to a binding molecule having influenza A virus-neutralizing activity derived from a human B cell, and the binding molecule having... |
| US-9,856,311 |
Synthetic immunoglobulin domains with binding properties engineered in
regions of the molecule different from... Libraries of immunoglobulins which each have one or more amino acid modifications in at least one structural loop region of such immunoglobulins, where the... |
| US-9,856,310 |
UTI fusion proteins The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same. |
| US-9,856,309 |
Fibronectin based scaffold domain proteins that bind PCSK9 The present invention relates to fibronectin based scaffold domain proteins that bind PCSK9. The invention also relates to the use of the innovative proteins in... |
| US-9,856,308 |
Spider silk fusion protein structures incorporating immunoglobulin
fragments as affinity ligands A recombinant fusion protein comprising the moieties Band CT, and optionally REP, wherein B is comprising at least one immunoglobulin fragment, which provides... |
| US-9,856,307 |
Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins
and uses thereof The present invention relates to soluble monomeric Anti-Mullerian Hormone Receptor type II (AMHRII) fusion proteins and uses thereof, in particular for... |
| US-9,856,306 |
Peptide pharmaceuticals for insulin resistance Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins... |
| US-9,856,305 |
Designer osteogenic proteins The invention relates to novel designer osteogenic proteins having altered affinity for a cognate receptor, nucleic acids encoding the same, and methods of use... |
| US-9,856,304 |
Peptide and application thereof Provided are a new peptide, a vector inserting a DNA that codes said peptide, a transformant obtained by transformation with that vector, and applications of... |
| US-9,856,303 |
BH3 peptides and method of use thereof The invention provides peptides and the nucleic acid sequences that encode them. The invention further provides therapeutic, diagnostic and research methods for... |
| US-9,856,302 |
Anti-microbial peptide and method for treating microbial infection An antimicrobial peptide which is a derivative of the peptide P-113. The amino acid sequence of the antimicrobial peptide is SEQ ID NO: 4 or SEQ ID NO: 5, in... |
| US-9,856,301 |
Anti-tumor properties of Dickkopf 3b The invention relates to novel therapeutic approaches to cancer treatment that exploits tumor suppressor functions of DKK3b by site-specific delivery of DKK3b.... |
| US-9,856,300 |
Dpy-30 binding peptides and methods of use Disclosed are compositions and methods for modulating Dpy-30 binding activity. The compositions may include peptides or peptidomimetics thereof that are related... |
| US-9,856,299 |
Use of immunesuppressant receptor The present invention relates to use of an antagonist of BIR1 (B cell immunoglobulin receptor 1) related to the present invention, a method for screening the... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.